Elicio Therapeutics Inc (ELTX)
10.01
+0.63
(+6.72%)
USD |
NASDAQ |
May 17, 16:00
10.01
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -22.80M |
June 30, 2023 | -17.61M |
September 30, 2022 | -14.90M |
Date | Value |
---|---|
June 30, 2022 | -9.517M |
March 31, 2021 | -6.073M |
March 31, 2020 | -2.507M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.80M
Minimum
Sep 2023
-2.507M
Maximum
Mar 2020
-12.24M
Average
-12.21M
Median
Cash from Operations (Quarterly) Benchmarks
Immuneering Corp | -15.49M |
Outlook Therapeutics Inc | -19.27M |
Amylyx Pharmaceuticals Inc | -0.489M |
NovaBay Pharmaceuticals Inc | -1.572M |
Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
Free Cash Flow Yield | -122.8% |